-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Opening Remarks

Symposia: Scientific Workshop on Understanding and Overcoming Tumor-intrinsic Resistance to CAR-T Therapies for Lymphoid Malignancies Program: Scientific Workshops
Friday, December 6, 2024: 2:00 PM-2:05 PM
Room 28 A-D (San Diego Convention Center)
Moderator:
and Jonathan H. Schatz, MD, University of Miami
Disclosures:
Schatz: Affimed NV: Consultancy; WCG: Consultancy; Acrotech Biopharma Inc.: Membership on an entity's Board of Directors or advisory committees.

This introduction will briefly review goals of the workshop and provide a roadmap of what's to come in the four sessions.

Jonathan H. Schatz, MD

University of Miami, Miami, FL